The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Immunome, Inc(NASDAQ:IMNM) 
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also devel...
Website: http://www.immunome.com
Founded: 2006
CEO: Purnanand D. Sarma
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Immunome Days Payable Outstanding ttm (DPO)
Immunome Days Receivable Outstanding ttm (DSO)
Immunome Op Cashflow Per Share ttm
Immunome Free Cashflow Per Share ttm
Immunome Cash Per Share ttm
Immunome P/S ratio ttm
Immunome (GAAP) P/E ratio ttm
Immunome P/B ratio ttm
No extra charts and metrics for this ticker.